Two major study retractions in one month have left researchers wondering if the peer review process is broken.
Tag: New England Journal of Medicine
Two Huge Covid-19 Studies Are Retracted After Scientists Sound Alarms
The reports, published in two leading journals, were retracted after authors could not verify an enormous database of medical records.
New Study Finds Hydroxychloroquine Did Not Prevent Covid-19
The first carefully controlled trial of hydroxychloroquine given to people exposed to the coronavirus did not show any benefit.
Scientists Question Medical Data Used in Second Coronavirus Study
Medical records from a little-known company were used in two studies published in major journals. The New England Journal of Medicine has asked to see the data.
Scientists Question Major Hydroxychloroquine Study
Experts demanded verification of data and methods used in a study of drugs to treat Covid-19. The study suggested the drugs might have increased deaths.
Scientists Question Validity of Major Hydroxychloroquine Study
Experts are demanding verification of data and methods used in a study of malaria drugs used to treat Covid-19. The study suggested the drugs may have increased deaths.
Remdesivir Coronavirus Trial: Federal Scientists Finally Publish Data
A clinical trial led to the authorization of the only drug shown to work in Covid-19 patients. But until now, few experts had seen the numbers.
Coronavirus May Pose a New Risk to Younger Patients: Strokes
Doctors have reported a flurry of cases in Covid-19 patients — including a healthy 27-year-old emergency medical technician in Queens. After a month in the hospital, he is learning to walk again.
‘It’s Really a Gift’: Israeli Hospitals Let Relatives Say Goodbye Up Close
A hospital spokesman asked why family members were barred from coronavirus wards when journalists could visit in protective gear. His bosses had no good answer.
M.R.I.s Can Better Detect Cancer in Women With Dense Breasts, Study Finds
A large study found that M.R.I.s detected tumors missed by mammograms, cutting interval cancers by half or more.